XML 45 R33.htm IDEA: XBRL DOCUMENT
v3.19.2

Financial Instruments and Fair Value Measurements (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2019
Fair Value Disclosures [Abstract] |
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table presents the Company’s fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (in thousands):
|  | June 30, 2019 |  |  | December 31, 2018 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money Market Funds |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4,504 |  |  | $ | — |  |  | $ | — |
Derivative financial instruments |  |  | — |  |  |  | 1,057 |  |  |  | — |  |  |  | — |  |  |  | 7,018 |  |  |  | — |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  |  | — |  |  |  | 37,354 |  |  |  | — |  |  |  | — |  |  |  | 7,304 |  |  |  | — |
Schedule of Derivative Financial Instruments | The Company had the following interest rate swaps and caps for the periods presented (dollars in thousands):
|  |  |  |  |  |  |  |  |  |  |  |  |  | Strike Rate |  |  |  |  | Fair Value |
Derivative Instrument |  | Aggregate Notional Amount |  |  | Effective Date |  |  | Maturity Date |  |  | Low |  |  |  |  | High |  |  | Balance Sheet Location |  | June 30, 2019 |  |  | December 31, 2018 |
Core |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest Rate Swaps |  | $ | 424,074 |  |  | Dec 2012-July 2020 |  |  | Mar 2022-July 2030 |  |  |  | 1.71 | % |  | — |  |  | 3.77 | % |  | Other Liabilities (a) |  | $ | (31,570 | ) |  | $ | (6,332 | )
Interest Rate Swaps |  |  | 163,500 |  |  | Oct 2014 - July 2016 |  |  | Nov 2019-June 2021 |  |  |  | 1.24 | % |  | — |  |  | 1.70 | % |  | Other Assets |  |  | 1,025 |  |  |  | 6,022 |
|  | $ | 587,574 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (30,545 | ) |  | $ | (310 | )
Fund II |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest Rate Swap |  | $ | 19,201 |  |  | Oct 2014 |  |  | Nov 2021 |  |  |  | 2.88 | % |  | — |  |  | 2.88 | % |  | Other Liabilities |  | $ | (150 | ) |  | $ | — |
Interest Rate Swap |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | — |  |  | — |  |  | Other Assets |  |  | — |  |  |  | 108 |
Interest Rate Cap |  |  | 23,300 |  |  | Mar 2019 |  |  | Mar 2022 |  |  |  | 3.50 | % |  | — |  |  | 3.50 | % |  | Other Assets |  |  | 9 |  |  |  | — |
|  | $ | 42,501 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (141 | ) |  | $ | 108 |
Fund III |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest Rate Cap |  | $ | 58,000 |  |  | Dec 2016 |  |  | Jan 2020 |  |  |  | 3.00 | % |  | — |  |  | 3.00 | % |  | Other Assets |  | $ | — |  |  | $ | 8 |
Fund IV |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest Rate Swaps |  | $ | 23,100 |  |  | Mar 2017 |  |  | Mar 2020 |  |  |  | 1.82 | % |  | — |  |  | 1.82 | % |  | Other Assets |  | $ | 23 |  |  | $ | 851 |
Interest Rate Swap |  |  | 70,114 |  |  | Mar 2017 - May 2019 |  |  | Apr 2022 - Dec 2022 |  |  |  | 1.97 | % |  | — |  |  | 4.00 | % |  | Other Liabilities |  |  | (878 | ) |  |  | — |
Interest Rate Caps |  |  | 108,900 |  |  | July 2016 - Nov 2016 |  |  | Aug 2019 - Dec 2019 |  |  |  | 3.00 | % |  | — |  |  | 3.00 | % |  | Other Assets |  |  | — |  |  |  | 8 |
|  | $ | 202,114 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (855 | ) |  | $ | 859 |
Fund V |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest Rate Swap |  | $ | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  | — |  |  | — |  |  | Other Assets |  | $ | — |  |  | $ | 21 |
Interest Rate Swaps |  |  | 156,900 |  |  | Jan 2018-Mar 2019 |  |  | Feb 2021-Mar 2024 |  |  |  | 2.27 | % |  | — |  |  | 2.88 | % |  | Other Liabilities |  |  | (4,756 | ) |  |  | (972 | )
|  | $ | 156,900 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (4,756 | ) |  | $ | (951 | )
Total asset derivatives |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 1,057 |  |  | $ | 7,018 |
Total liability derivatives |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (37,354 | ) |  | $ | (7,304 | )
| (a) | Includes two swaps with an aggregate fair value of ($10.6) million and ($2.9) million at June 30, 2019 and December 31, 2018, respectively, which were acquired during July 2018 and are not effective until July 2020.
Schedule of Other Financial Instruments Carrying Values and Fair values | The Company’s other financial instruments had the following carrying values and fair values as of the dates shown (dollars in thousands, inclusive of amounts attributable to noncontrolling interests where applicable):
|  |  |  |  |  | June 30, 2019 |  |  | December 31, 2018 |
|  | Level |  |  | Carrying Amount |  |  | Estimated Fair Value |  |  | Carrying Amount |  |  | Estimated Fair Value |
Notes Receivable (a) |  |  | 3 |  |  | $ | 94,662 |  |  | $ | 93,532 |  |  | $ | 109,613 |  |  | $ | 107,370 |
Mortgage and Other Notes Payable (a) |  |  | 3 |  |  |  | 1,035,677 |  |  |  | 1,040,198 |  |  |  | 1,026,708 |  |  |  | 1,021,075 |
Investment in non-traded equity securities (b) |  |  | 3 |  |  |  | — |  |  |  | 23,208 |  |  |  | — |  |  |  | 23,208 |
Unsecured notes payable and Unsecured line of credit (c) |  |  | 2 |  |  |  | 660,025 |  |  |  | 660,734 |  |  |  | 533,625 |  |  |  | 533,954 |
(a) | The Company determined the estimated fair value of these financial instruments using a discounted cash flow model with rates that take into account the credit of the borrower or tenant, where applicable, and interest rate risk. The Company also considered the value of the underlying collateral, taking into account the quality of the collateral, the credit quality of the borrower, the time until maturity and the current market interest rate environment.
(b) | Represents Fund II’s cost-method investment in Albertson’s supermarkets (Note 4).
(c) | The Company determined the estimated fair value of the unsecured notes payable and unsecured line of credit using quoted market prices in an open market with limited trading volume where available. In cases where there was no trading volume, the Company determined the estimated fair value using a discounted cash flow model using a rate that reflects the average yield of similar market participants.

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13467-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration